Budesonide Market Report
The report on the Budesonide Market is segmented By Type (Injectable Suspension, Aerosols, Inhalation Powder, Tablet & Capsule), By Application (Respiratory Disease Treatment, Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Others), and Region. This report also covers COVID-19 Impact Analysis and Forecast to 2026.This market research report provides an in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global budesonide market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
The report on the Budesonide Market is segmented By Type (Injectable Suspension, Aerosols, Inhalation Powder, Tablet & Capsule), By Application (Respiratory Disease Treatment, Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Others), and Region. ...
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The Budesonide Market is estimated to grow from USD xx million in 2020 to USD xx million by 2026 at a healthy CAGR of xx% during the forecast period.
Budesonide is primarily used to prevent and control symptoms such as shortness and wheezing of breath caused by asthma. It belongs to a class of drugs known as corticosteroids. It mainly works directly to the lungs to make breathing easier by reducing the swelling and irritation of the airways. Budesonide is sold under the brand name Pulmicort, which is a steroid medication.
Key players operating in the budesonide market are-
The rising prevalence of asthma around the globe, strong growth in healthcare infrastructure, the surge in the diagnosis and treatment rate of asthma, and favourable reimbursement policies are some of the key factors augmenting the industry growth.
In addition, the strong emergence of generic companies, expiry of patented drugs, growing R&D investment, and technological development in the medical industry are expected to offer growth opportunities during the review period.
Based on application, the Budesonide market is classified into respiratory disease treatment, nose disease treatment, inflammatory bowel disease treatment, and others.
By region, the Asia Pacific market accounted for the largest share in 2020 and is expected to grow at a substantial CAGR in the following years.
The COVID-19 outbreak has moderately affected the budesonide industry. Due to stringent lockdown and social distance norms, there are limited production activities and a limited supply of raw material supply. Limited workforce and shutdown of operations are further affected by the industry growth. However, rising respiratory illness during the pandemic is expected to create a demand for budesonide, thus driving the industry's growth.
Here is the list of the group of customers that the Budesonide market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected]
AstraZeneca (UK), Teva (Israel), Mylan (The U.S), Sandoz (Switzerland), Cosmo Pharmaceuticals (Ireland), Salix (The U.S), Chiesi Farmaceutici (Italy), Orion Corporation (Finland), Cipla (India) and Synmosa Biopharma (Taiwan) are among the key players in the budesonide market.
Asia Pacific market accounted for the largest share in 2020 and is expected to grow at a substantial CAGR.
China is expected to dominate the budesonide market in Asia-pacific region in the coming years.
The respiratory disease treatment segment is expected to grow at the highest CAGR in the budesonide market during the forecast period.
The rising prevalence of asthma around the globe, strong growth in healthcare infrastructure, the surge in the diagnosis and treatment rate of asthma, and favourable reimbursement policies are the factors driving the growth of budesonide market.
Budesonide vendors, Budesonide retailers, Pharmaceutical companies, Hospitals are the target audience in the budesonide market.